Eko Foundation Analysis Software with Transformers (EFAST) vs Stethee Pro 1

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Eko's EFAST is designed for clinicians prioritizing highly sensitive and specific AI detection of structural murmurs and atrial fibrillation during routine cardiac exams. Stethee Pro 1, conversely, offers a comprehensive AI-enabled wireless digital stethoscope system for broader real-time cardiac and respiratory vital sign analysis, including advanced sound visualization and environmental data tagging. Both are FDA-cleared digital stethoscopes with AI capabilities, but their primary diagnostic focus areas differ.

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose EFAST if your primary need is real-time, AI-powered assistance for detecting specific cardiac conditions like structural murmurs and atrial fibrillation during in-person auscultation. This tool is ideal for clinicians using Eko digital stethoscopes who require immediate, highly sensitive, and specific diagnostic insights to inform patient care during routine examinations.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Choose Stethee Pro 1 if…

Choose Stethee Pro 1 if you require a versatile, wireless digital stethoscope system for both advanced cardiac and respiratory diagnostics, particularly in telemedicine or remote monitoring scenarios. Its ability to capture comprehensive vital signs in seconds, coupled with sophisticated sound amplification, mobile app integration, and environmental data tagging, makes it suitable for broad diagnostic applications and secure data sharing across distributed care settings.

View Stethee Pro 1 →

When choosing between Eko Foundation Analysis Software with Transformers (EFAST) and Stethee Pro 1, physicians should consider their primary diagnostic focus and workflow. EFAST, integrated with Eko digital stethoscopes, excels in real-time, AI-powered detection of structural murmurs associated with heart disease and atrial fibrillation during routine auscultation. Its strength lies in providing immediate, actionable cardiac insights with high sensitivity and specificity for these specific conditions. EFAST is best suited for clinicians, particularly in cardiology, family medicine, and internal medicine, who prioritize efficient, AI-assisted screening for common cardiac pathologies directly at the point of care.

In contrast, Stethee Pro 1 offers a broader scope, providing real-time cardiac and respiratory vital sign analysis, including heart cycle durations and respiration rates, in addition to advanced sound amplification and filtering. While it also features AI, its focus is on comprehensive vital sign capture and visualization of both heart and lung sounds, making it valuable for a wider range of diagnostic scenarios. The key practical difference is EFAST’s specialized, high-accuracy AI for specific cardiac conditions versus Stethee Pro 1’s more generalized vital sign and sound analysis across both cardiac and respiratory systems. Physicians in emergency medicine or pulmonology, or those requiring a more holistic view of cardiorespiratory function and environmental data tagging, might find Stethee Pro 1 more aligned with their needs.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Foundation Analysis Software with Transformers (EFAST) Stethee Pro 1
Pricing Subscription-based, contact for details $499 (device); subscription for stethee central web portal
Deployment Cloud-based Software as a Medical Device (SaMD) Cloud-based (Stethee Central Web Portal) and mobile application (iOS/Android)
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

Tool A (EFAST) emphasizes 'seamless integration with Eko digital stethoscopes' and 'guided exams,' suggesting a highly integrated and user-friendly experience within its ecosystem. While Tool B (Stethee Pro 1) offers wireless and mobile flexibility, Tool A's explicit mention of guided exams points to a potentially smoother learning curve and workflow for clinicians.

Clinical Value

Eko Foundation Analysis Software with Transformers (EFAST)

Tool A (EFAST) provides specific, high-accuracy performance metrics for detecting critical cardiac conditions: 93% sensitivity and 91% specificity for structural murmurs, and 95% sensitivity and 94% specificity for AFib. Tool B (Stethee Pro 1) offers broader cardiac and respiratory vital sign analysis but lacks comparable specific disease detection metrics in the provided facts, making Tool A's clinical impact more clearly defined and validated for its target conditions.

Pricing & Value

Stethee Pro 1

Tool B (Stethee Pro 1) offers transparent pricing with a clear upfront device cost of $499 and a separate subscription for its web portal. Tool A (EFAST) has less transparent pricing, stating 'subscription-based, contact for details' for the software, making it harder to assess the total cost of ownership and overall value without direct inquiry.

Enterprise Readiness

Eko Foundation Analysis Software with Transformers (EFAST)

Both tools are HIPAA compliant and cloud-based. However, Tool A (EFAST) explicitly states 'EMR integration for streamlined documentation' and confirms a Business Associate Agreement (BAA) is in place. While Tool B (Stethee Pro 1) mentions secure data sharing and that data can be imported into patients' medical records, Tool A's direct mention of EMR integration and explicit BAA provides stronger indicators for enterprise adoption and seamless workflow integration.

Innovation

Stethee Pro 1

Tool B (Stethee Pro 1) stands out with its claim as 'The World's First AI-Enabled Wireless Stethoscope System' and its unique feature of 'Automatic geo-location and environmental data tagging (humidity, temperature, pollen count, pollution).' While Tool A (EFAST) offers advanced AI for specific cardiac detections, Tool B's broader system-level innovation, including novel data capture and environmental context, presents a more expansive view of innovation.

Support & Docs

Tie

Both Eko Health and M3DICINE provide support resources, including FAQs, user manuals, and contact options on their respective websites. Without more detailed information on the quality, responsiveness, or depth of their support and documentation, it is not possible to definitively distinguish between the two tools in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Foundation Analysis Software with Transformers (EFAST) Stethee Pro 1
Product Name Eko Foundation Analysis Software with Transformers (EFAST) Stethee Pro 1
Company Eko Health M3DICINE Pty Ltd.
Key AI Detections AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity) Real-time cardiac and respiratory vital sign analysis; Measures systole, diastole, heart cycle durations, and respiration rate
Sound Enhancement Features Enhanced audio with noise cancellation and amplification Sophisticated sound amplification (up to 96x) and 5 proprietary digital filters
Visualization Capabilities Waveform visualization and guided exams Real-time visualization of heart (PCG, AIDA Cycle, AIDA Energy) and lung sounds (spectrogram)
EMR Integration EMR integration for streamlined documentation Not specified

Videos

Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and Stethee Pro 1.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Foundation Analysis Software with Transformers (EFAST) is an FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation. Stethee Pro 1 is an AI-enabled wireless digital stethoscope system that provides real-time cardiac and respiratory vital sign analysis, including measures of systole, diastole, heart cycle durations, and respiration rate.
EFAST provides specific performance metrics, boasting 93% sensitivity and 91% specificity for AI-powered structural murmur detection, and 95% sensitivity and 94% specificity for AI-powered atrial fibrillation detection. Stethee Pro 1 captures cardiac and respiratory vital signs in 20 seconds, but specific sensitivity and specificity metrics for its AI diagnostic capabilities are not detailed in the provided information.
EFAST requires seamless integration with Eko digital stethoscopes, such as the CORE 500, and offers EMR integration for streamlined documentation. Stethee Pro 1 is a complete AI-enabled wireless digital stethoscope system that includes its own device, offering a mobile app (iOS/Android) and a HIPAA compliant Central Web Portal for data management and sharing.
While EFAST focuses on cardiac murmurs and AFib, Stethee Pro 1 extends its capabilities to include comprehensive respiratory vital sign analysis and visualization of lung sounds via a spectrogram. Stethee Pro 1 also uniquely offers automatic geo-location and environmental data tagging, such as humidity, temperature, pollen count, and pollution.
EFAST is designed for Cardiology, Family Medicine, and Internal Medicine, focusing on common cardiac conditions. Stethee Pro 1 targets Cardiology, Emergency Medicine, and Pulmonology, reflecting its broader capabilities in both cardiac and respiratory diagnostics.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.